News

Did Johnson & Johnson put profit over safety? | The Excerpt
For generations of Americans the Johnson & Johnson brand has been a beloved one, as quintessentially American as baseball and ...
Fierce Pharma1d
J&J's Darzalex wins FDA advisors' backing as potential first treatment for smoldering myeloma
Johnson & Johnson has won the support of an FDA expert panel in its bid to make Darzalex the first treatment for an early ...
Johnson & Johnson (NYSE:JNJ) Hit with $147M Verdict in Landmark Antitrust Case Over Reprocessed Medical Devices
A federal jury in Santa Ana has ordered Johnson & Johnson (NYSE:JNJ) to pay $147 million after its Biosense Webster unit was ...
The FDA Takes a Trial-Lawyer Turn
Commissioner Makary touts dubious evidence on talcum powder at a rushed hearing.
Medscape15h
FDA Advisory: Daratumumab Wins for Smoldering Myeloma Glofitamab Loses for Early Line R/R Diffuse Large B-Cell Lymphoma
The FDA is likely to approve the first treatment for smoldering multiple myeloma but pass on a new option relapsed/refractory DLBCL, after votes by its Oncologic Drugs Advisory Committee.
MassDevice2d
Johnson & Johnson hit with $147M antitrust verdict
A federal jury has ordered Johnson & Johnson's Biosense Webster business to pay $147 million to a cardiac mapping catheter ...
J&J Says FDA Advisory Panel Favors Benefit-Risk Profile of Darzalex Faspro in Myeloma Treatment
The pharmaceutical company said Tuesday the FDA's Oncologic Drugs Advisory Committee voted 6-2 in favor of Darzalex Faspro, or daratumumab and hyaluronidase-fihj, to treat adult patients with ...
FDA Changes How COVID Vaccines Will Be Approved—Here’s What To Know
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...